Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024


Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the J.P. Morgan 42nd Annual Healthcare Conference on Tuesday, January 9, 2024, at 10:30 am PT (1:30 pm ET).

The presentation will be webcast live; a link for the webcast can be found on the Edgewise events page and will be accessible for replay following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.

About Edgewise Therapeutics

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company's deep expertise in muscle physiology is driving a new generation of first-in-class therapeutics. EDG-5506 is an orally administered skeletal myosin inhibitor in clinical trials in patients with Becker, Duchenne, and Limb-Girdle muscular dystrophies as well as McArdle Disease. EDG-7500, currently in a Phase 1 trial, is a novel cardiac sarcomere modulator for the treatment of HCM and other disorders of cardiac diastolic dysfunction. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram and Threads.


These press releases may also interest you

at 17:45
Cut+Dry and Cheney Bros Inc. Announce New Strategic Partnership
Cheney Bros Inc., a leading family-owned and operated broadline food distributor serving the Southeastern United States, is pleased to announce a strategic partnership with Cut+Dry, the foodservice industry's premier e-commerce platform. This...

at 17:35
Kneat Announces Record Revenue for First Quarter 2024
kneat.com, inc. ("Kneat" or the "Company") a leader in digitizing and automating validation and quality processes, today announced financial results for the three-month period ended March 31, 2024. All dollar amounts are presented in Canadian...

at 17:35
Underwater Camera Market size to record USD 3.64 billion growth from 2023-2027, Bundle packaging is one of the key market trends, Technavio
The global underwater camera market size is estimated to grow by USD 3.64 billion from 2023 to 2027, according to Technavio. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of almost 11.68% during the forecast period....

at 17:30
Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to Evaluate PT217 in Combination with an anti-PD-L1 Therapy
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...

at 17:30
GO Car Wash Marks Five-Year Milestone with Explosive Growth to 145 Locations
In just five years, GO Car Wash has transformed from a startup to an industry powerhouse with 145 locations nationwide, growing three times faster than the industry average. "We are proud of our expansion to 145 locations through acquisitions and...

at 17:15
"Make Your Mother's Day" with MoneyGram's AI-Generated Cards Guaranteed to Make Mom Laugh
In advance of Mother's Day, one of the most significant holidays for the cross-border payments industry, MoneyGram has launched "Make Your Mother's Day," a funny and memorable way to celebrate moms ? no matter where they are in the world. ...

More news about Science and technology...


News published on and distributed by: